SEC Form 4 · accession 0001144204-17-017748
CV Sciences, Inc. · CVSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph D Dowling
Officer — Chief Financial Officer
Period of report
Mar 15, 2017
Accepted (ET)
Mar 30, 2017 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510964
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $0.38 | Mar 15, 2017 | A | 100,000 | A | — | Mar 14, 2027 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The option is fully vested on the date of grant.